Quest Diagnostics Incorporated Share Price
Equities
DGX
US74834L1008
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 190.26 USD | +1.87% |
|
+7.04% | +9.64% |
| 15/01 | Sonora Quest and Laboratory Sciences of Arizona announce Jennifer Erickson as CEO-elect | RE |
| 13/01 | Baird Adjusts Quest Diagnostics Price Target to $203 From $198, Maintains Neutral Rating | MT |
| Capitalization | 2.12TCr 1.82TCr 1.7TCr 1.58TCr 2.94TCr 1,91200Cr 3.15TCr 20TCr 7.68TCr 91TCr 7.94TCr 7.77TCr 3,35400Cr | P/E ratio 2025 * |
22.1x | P/E ratio 2026 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise value | 2.65TCr 2.29TCr 2.13TCr 1.98TCr 3.69TCr 2,39700Cr 3.95TCr 24TCr 9.63TCr 1,14600Cr 9.95TCr 9.74TCr 4,20400Cr | EV / Sales 2025 * |
2.41x | EV / Sales 2026 * | 2.31x |
| Free-Float |
67.83% | Yield 2025 * |
1.62% | Yield 2026 * | 1.64% |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | +1.87% | ||
| 1 week | +7.04% | ||
| Current month | +9.64% | ||
| 1 month | +3.34% | ||
| 3 months | +1.55% | ||
| 6 months | +14.33% | ||
| Current year | +9.64% |
| 1 week | 173.51 |  | 190.99 |
| 1 month | 171.18 | | 190.99 |
| Current year | 171.18 | | 190.99 |
| 1 year | 150.14 | | 197.55 |
| 3 years | 119.59 | | 197.55 |
| 5 years | 113.36 | | 197.55 |
| 10 years | 59.66 | | 197.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 03/02/2022 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 11/07/2022 |
Kristin Wallace
CMP | Compliance Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 01/12/2004 |
Timothy Ring
BRD | Director/Board Member | 69 | 07/12/2011 |
James Davis
CHM | Chairman | 63 | 01/04/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.27% | 14.84% | 303 M€ | |
| 0.00% | 2.17% | 2 M€ | |
| 0.00% | 2.05% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.87% | +7.04% | +26.56% | +28.61% | 2.12TCr | |
| +1.04% | +1.00% | +57.98% | +86.89% | 11TCr | |
| +2.56% | +0.94% | +56.04% | -9.52% | 10TCr | |
| +1.69% | +2.90% | +42.30% | +77.44% | 3.25TCr | |
| -0.46% | +4.73% | -13.25% | +16.86% | 2.42TCr | |
| +2.63% | +5.58% | +13.31% | +6.83% | 2.23TCr | |
| +3.14% | -1.00% | +54.83% | +289.17% | 1.77TCr | |
| -0.05% | -0.86% | +49.11% | +53.31% | 1.66TCr | |
| +2.49% | -3.29% | +11.22% | +38.08% | 1.28TCr | |
| +0.80% | -5.65% | -16.85% | +9.81% | 1.2TCr | |
| Average | +1.57% | +0.87% | +28.13% | +59.75% | 3.73TCr | |
| Weighted average by Cap. | +1.66% | +1.22% | +42.45% | +50.68% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.1TCr 947.06Cr 882.58Cr 821.08Cr 1.53TCr 99TCr 1.64TCr 10TCr 3.99TCr 47TCr 4.12TCr 4.04TCr 1,74200Cr | 1.14TCr 980.76Cr 913.99Cr 850.3Cr 1.58TCr 1,02900Cr 1.7TCr 11TCr 4.13TCr 49TCr 4.27TCr 4.18TCr 1,80400Cr |
| Net income | 98Cr 85Cr 79Cr 73Cr 136.43Cr 8.87TCr 146.36Cr 905.74Cr 356.4Cr 4.24TCr 368.23Cr 360.69Cr 16TCr | 105.09Cr 91Cr 84Cr 78Cr 146.01Cr 9.49TCr 156.62Cr 969.29Cr 381.41Cr 4.54TCr 394.06Cr 386Cr 17TCr |
| Net Debt | 536.47Cr 462.12Cr 430.66Cr 400.65Cr 745.36Cr 48TCr 799.56Cr 4.95TCr 1.95TCr 23TCr 2.01TCr 1.97TCr 85TCr | 509.34Cr 438.75Cr 408.88Cr 380.39Cr 707.66Cr 46TCr 759.13Cr 4.7TCr 1.85TCr 22TCr 1.91TCr 1.87TCr 81TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 190.26 $ | +1.87% | 12,45,699 |
| 14/26/14 | 186.77 $ | +3.78% | 14,98,946 |
| 13/26/13 | 179.96 $ | +2.28% | 10,69,588 |
| 12/26/12 | 175.94 $ | +0.86% | 6,95,248 |
| 09/26/09 | 174.44 $ | -1.86% | 9,42,357 |
Delayed Quote Nyse, January 16, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition